Russian Reality

An immunologist admitted a decrease in the effectiveness of the COVID-19 vaccine against the omicron strain coronavirus omicron. Experts allowed the development of events in which protection against vaccination would become less reliable. Opinions are conveyed by URA.RU. “The evolution of viruses is moving towards a change in the structure of the protein so that the vaccine does not act on it. Delta (the delta coronavirus strain became dominant in the summer of 2021 and gradually replaced almost all other variants of the virus in the world – approx. “Lenta.ru” ) in India reduced the effect by 20-30 percent. You have to wait to see, “- said Vladislav Zhemchugov, an immunologist, a specialist in especially dangerous infections. Related materials00: 01 – October 25 ” Mild epidemic of dementia “Russians do not want to be vaccinated and observe antiquated measures. What do doctors say about this? 12:50 – November 11 COVID

The injured at the plant in Dzerzhinsk are in a state of moderate severity moderate severity. Interfax was informed about this by the regional Ministry of Health. “Two victims were taken to medical organizations in Dzerzhinsk. Doctors assess their condition as moderate, they are provided with the necessary assistance, ”the doctors said. The incident at the Sverdlov ammunition and explosives plant in Dzerzhinsk, Nizhny Novgorod Region, became known on the morning of November 27. According to preliminary data, a fire started in one of the workshops, due to which there were two explosions. The building partially collapsed. Operational services work on the spot. Neighboring businesses have been evacuated. The reasons for the fire at the plant could be a violation of the technological process and equipment malfunction.

Online-Ipoteka: 21 percent of Russians sell property to pay the first mortgage payment In most cases, Russians use only the accumulated funds. This method is used by 46 percent of the respondents. The sources of funds for the payment of a part of the loan for housing are disclosed in the research of the online-Ipoteka mortgage lending platform, RIA Novosti reports. The study involved 3.7 thousand Russians who have taken out a mortgage loan over the past five years. To pay the first installment for housing, 21 percent of respondents sell property, and 19 percent of respondents use accumulated savings and maternity capital. Some home buyers borrow money from relatives or friends (8 percent of respondents) or take out consumer loans (6 percent of respondents) for the first installment. As for the amount of the contribution, 38 percent of respondents contributed an amount of 1, 5 to 2.5 million rubles,

Mash: Mark Rudinstein underwent an operation to form an artificial hole in his neck – an operation to form an artificial opening in the neck, reports Telegram-channel Mash. It is noted that the 75-year-old creator of the Kinotavr festival remains on a ventilator in intensive care with severe brain damage due to extensive ischemic stroke. Rudinstein was hospitalized with a heart attack on November 17, doctors diagnosed him with myocardial infarction. Later it became known that the producer fell into a coma.

Director of the Center. Gamalei Gunzburg: COVID-19 drug trials will begin in 2022 Russian scientists from the Center. N.F. The Gamalei plan to start testing a domestic drug for COVID-19 in early 2022. The director of the center, Alexander Gintsburg, announced the deadline, TASS reports. “Our institute is already developing a cocktail of monoclonal antibodies, which we will start testing in the first days of the coming [year],” the scientist shared his plans. < p> The center is faced with the task of creating a means that would suppress the reproduction of any virus strain. Gunzburg noted that the development and testing of such a drug requires the involvement of a large amount of resources. “It costs insane money. Nevertheless, the Moscow government buys this drug for the treatment of pregnant women, “- said the scientist. Earlier in the Center. N.F. The Gamaleys answered whether a new vaccine would be